# Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency

> **NCT03309891** · PHASE2 · COMPLETED · sponsor: **Genexine, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** GX-H9
- **DRUG:** Genotropin

## Key facts

- **NCT ID:** NCT03309891
- **Lead sponsor:** Genexine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-18
- **Primary completion:** 2017-10-27
- **Final completion:** 2019-05-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03309891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03309891, "Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03309891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*